Intensity Therapeutics is a late-stage clinical biotechnology company focused on developing intratumoral therapies for solid tumors. The company's lead product candidate, INT230-6, is designed to kill tumors and elicit an immune response when injected directly into the tumor.
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.